Kidney Cancer Stage Migrated Downward in Low-Income Patients After ACA
Higher proportions of patients in the low to middle income brackets were diagnosed with localized renal cell carcinoma in states allowing Medicaid expansion.
All articles by Natasha Persaud
Most Patients With Local or Regional Prostate Cancer Die From Other Causes
Understanding causes of death in contemporary patients with prostate cancer is essential for proper survivorship management, according to investigators.
Radiation May Provide Some Oncologic Control in High-Risk NMIBC
Trial data are still needed to clearly define the risks and benefits of using radiation therapy for nonmuscle-invasive bladder cancer, according to investigators.
Gene Therapy for NMIBC Effective Regardless of Patient Characteristics
In a subgroup analysis, neither patient characteristics nor prior treatment history influenced response to a novel intravesical gene therapy for BCG-unresponsive bladder cancer.
Prior Radiation Linked to Worse Survival in Bladder Cancer Cases
This study examined bladder cancer that developed after radiation for any cancer potentially affecting the organ, not just prostate cancer.
PSA Density Kinetics Predict Prostate Cancer Progression on AS
PSA density is routinely collected as part of prostate cancer active surveillance protocols, so monitoring kinetics confers no extra costs or burdens on patients, according to investigators.
No Higher Death Risk for Black Men on Active Surveillance for Low-Risk PCa
At 7.6 years, prostate cancer-specific and all-cause mortality were not significantly different among Black and White veterans.
Study Supports Salvage Over Adjuvant RT After Prostate Surgery
Initial results from the RADICALS-RT study do not support routine administration of adjuvant radiation therapy after radical prostatectomy in patients at elevated risk for prostate cancer recurrence.
Neoadjuvant and Adjuvant Chemo More Effective Than RNU Alone in UTUC
As current guidelines only include a weak recommendation to offer perioperative chemotherapy to patients with muscle-invasive upper tract urothelial carcinoma, a new meta-analysis including evidence up to February 2020 provides potentially useful information.
Neoadjuvant Chemo May Improve Overall Survival in UTUC
Survival was significantly improved in patients with greater disease burden.
-
Loading...
-
Loading...
Next post in Bladder Cancer
